About
Our Story
Our People
Our Advisors
Science
Pipeline
Izokibep
Lonigutamab
SLRN-517
Presentations & Publications
Community
Patients
Partnerships
Investors & Media
Overview
Press Releases
Events & Presentations
Financials & Filings
Corporate Governance
Email Alerts
Investor Resources
Media Resources
Careers
Stories
Contact Us
Presentation
Izokibep Demonstrates Major Disease Control on ACR70, PASI100 and Enthesitis Resolution in Patients with Active Psoriatic Arthritis Treated Through 46 Weeks
November 14, 2023
Share
Download Presentation
Copy